Cargando…

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma

Therapeutic options for locally advanced pancreatic cancer (LAPC) include concurrent chemoradiation, induction chemotherapy followed by chemoradiation or systemic therapy alone. The original Gastro-Intestinal Study Group and Eastern Cooperative Oncology Group studies defined fluorouracil (5-FU) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	SAIF, MUHAMMAD WASIF, LEDBETTER, LESLIE, KALEY, KRISTIN, GARCON, MARIE CARMEL, RODRIGUEZ, TERESA, SYRIGOS, KOSTAS N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114599/ https://www.ncbi.nlm.nih.gov/pubmed/25120712 http://dx.doi.org/10.3892/ol.2014.2238

Ejemplares similares

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)

Hypokalemia secondary to capecitabine: a hidden toxicity?
por: Saif, Muhammad Wasif, et al.
Publicado: (2007)

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
por: Kotteas, Elias A, et al.
Publicado: (2016)

Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real Phenomenon
por: Saif, Muhammad Wasif, et al.
Publicado: (2019)

Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension
por: Saif, Muhammad W, et al.
Publicado: (2016)

Targeting cancers in the gastrointestinal tract: role of capecitabine
por: Saif, Muhammad Wasif
Publicado: (2009)

CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Genetic factors affecting patient responses to pancreatic cancer treatment
por: Fotopoulos, George, et al.
Publicado: (2016)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012)

Role and Cost Effectiveness of PET/CT in Management of Patients with Cancer
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population
por: Jiang, Zhenyang, et al.
Publicado: (2016)

Role of Vitamin D in the Prevention of Pancreatic Cancer
por: Bulathsinghala, Pubudu, et al.
Publicado: (2010)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
por: Wang, Yan, et al.
Publicado: (2016)

Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma
por: Mohammad, Mustafa M., et al.
Publicado: (2013)

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer
por: Chadha, Awalpreet S., et al.
Publicado: (2016)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2016)

Does Ablation Technique Utilized in the Management of Unresectable Locally Advanced Pancreatic Adenocarcinoma?
por: Pezzilli, Raffaele, et al.
Publicado: (2010)

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial
por: Chen, Ming-Huang, et al.
Publicado: (2016)

Unresectable Pancreatic Adenocarcinoma: Eight Years Later
por: Smiley, Kate, et al.
Publicado: (2016)

Pancreatic Tuberculosis or Autoimmune Pancreatitis
por: Salahuddin, Ayesha, et al.
Publicado: (2014)

Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer
por: Suzukida, Jillian, et al.
Publicado: (2016)

Safety and Efficacy of s-MOX Regimen in Patients with Colorectal Cancer Who Developed Cardiotoxicity Following Fluoropyrimidine Administration: A Case Series
por: Ehrlich, Matthew I., et al.
Publicado: (2020)

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
por: Kornek, G V, et al.
Publicado: (2000)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
por: Hosein, Peter J, et al.
Publicado: (2012)

Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma
por: Dyer, Brandon A, et al.
Publicado: (2015)

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Metastatic Cervical Carcinoma to the Thyroid Gland: A Case Report and Review of the Literature
por: Karapanagiotou, Elena, et al.
Publicado: (2007)

2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer
por: Russo, Suzanne, et al.
Publicado: (2016)

Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease
por: Saif, Muhammad W, et al.
Publicado: (2017)

Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer
por: Ziemons, Janine, et al.
Publicado: (2023)

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?
por: Rosumeck, Nathalie, et al.
Publicado: (2021)

The Biological Role of PI3K Pathway in Lung Cancer
por: Sarris, Evangelos G., et al.
Publicado: (2012)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation
por: Lee, Guk Jin, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jc9kni6fhk4kqbo4ndjvb382j0